Monday, December 5, 2011

Ohio Medicaid program gets $676K in drug firm settlement - Denver Business Journal:

utyziluz.wordpress.com
Paris-based reached a $182.8 million settlement with all 50 stateasand Washington, D.C., after attorneys generalk nationwide mounted an investigationj into the company's alleged overbilling for an anti-nausea drug typically used in chemotherapgy treatments. Ohio Attorney General Marc Dann and othe r officials claim the company inflateed average wholesale prices for the drug betweenj June 1997 andSeptember 2004.
Michelle Gatchell, a spokeswoman for Dann's office, said about 165,000 Anzemer prescriptions were filled in Ohio duringthat "My office will continue to look into the pharmaceuticalp industry to make sure no other company is takingy advantage of the system or Ohioans," Dann said in a Dann is involved in similar lawsuits pendinhg against Columbus-based , Abbotyt Park, Ill.-based (NYSE: ABT), Peapack, N.J.-based and Nev.-based The federal government's Medicarw program is receiving $160.11 million of the Aventis settlement, while the rest will be funnelerd to state Medicaid programs. Officialxs at the company, now named (NYSE: couldn't be reached immediatelu for comment.
Ohio's Medicaid program, startedf in 1968, assists 1.7 million Ohioans a mont on average, and abougt 2.2 million throughout the year. The $13.3 billionn program, which takes up about a quarter ofthe state's annual budget, serve s children and adults in low-incomer Ohio families.

No comments:

Post a Comment